Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Vulvar Neoplasms 2Melanoma 2Liver Metastases 2Breast Neoplasms 2Ulcer 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Pathologic Processes 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Liver Neoplasms 1Head and Neck Neoplasms 1Gynecological Cancers 1Colorectal Neoplasms 1

Interventions

pembrolizumab 3Paclitaxel 2relatlimab 1nintedanib 1lifileucel 1dabrafenib 1Vitamin D 1Temozolomide 1Surveys and Questionnaires 1Opdualag 1Nivolumab 1Ipilimumab 1Eye Movement Desensitization Reprocessing 1Electrochemotherapy 1Dacarbazine 1Cholecalciferol 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Melanoma, Cutaneous Malignant × Electrochemotherapy × Clear all
NCT06388252 2026-02-19

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Institute of Oncology Ljubljana

Phase NA Enrolling by invitation
10 enrolled
Dermatologic

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡